Beijing Innocare Pharma Tech
Clinical trials sponsored by Beijing Innocare Pharma Tech, explained in plain language.
Now part of
InnoCare Pharma Limited
9969
HKEX
A Chinese pharmaceutical company developing and commercializing drugs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug ICP-538 tested in healthy people for first time Results expected Sep 2026 (estimated)
- New pill could ease severe psoriasis in just 12 weeks Results expected Oct 2026 (estimated)
- New pill could tame tough eczema without creams Results expected Nov 2026 (estimated)
- New pill could stop the maddening itch of prurigo nodularis Results expected Mar 2027 (estimated)
- New pill could tame skin lupus flares Results expected Mar 2027 (estimated)